レナサイエンスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/06/30 | 1,777 | 1,840 | 1,732 | 1,813 | -4 | -0.2% | 1,015,500 |
| 2025/06/27 | 1,980 | 2,020 | 1,782 | 1,817 | -129 | -6.6% | 1,635,300 |
| 2025/06/26 | 2,003 | 2,026 | 1,888 | 1,946 | -21 | -1.1% | 996,400 |
| 2025/06/25 | 2,029 | 2,075 | 1,959 | 1,967 | -53 | -2.6% | 714,600 |
| 2025/06/24 | 2,145 | 2,168 | 2,020 | 2,020 | -75 | -3.6% | 907,100 |
| 2025/06/23 | 2,064 | 2,120 | 2,022 | 2,095 | -8 | -0.4% | 589,000 |
| 2025/06/20 | 2,163 | 2,262 | 2,065 | 2,103 | -50 | -2.3% | 774,900 |
| 2025/06/19 | 2,222 | 2,270 | 2,132 | 2,153 | -138 | -6% | 946,200 |
| 2025/06/18 | 2,058 | 2,355 | 2,058 | 2,291 | +336 | +17.2% | 3,826,700 |
| 2025/06/17 | 2,024 | 2,058 | 1,914 | 1,955 | -37 | -1.9% | 850,000 |
| 2025/06/16 | 2,012 | 2,038 | 1,937 | 1,992 | -10 | -0.5% | 702,600 |
| 2025/06/13 | 2,106 | 2,138 | 1,957 | 2,002 | -95 | -4.5% | 1,100,100 |
| 2025/06/12 | 1,983 | 2,125 | 1,981 | 2,097 | +108 | +5.4% | 1,518,000 |
| 2025/06/11 | 2,124 | 2,127 | 1,927 | 1,989 | -135 | -6.4% | 1,839,300 |
| 2025/06/10 | 2,048 | 2,145 | 1,985 | 2,124 | +93 | +4.6% | 1,986,400 |
| 2025/06/09 | 1,890 | 2,134 | 1,885 | 2,031 | +144 | +7.6% | 4,192,800 |
| 2025/06/06 | 1,890 | 1,957 | 1,805 | 1,887 | +23 | +1.2% | 3,813,900 |
| 2025/06/05 | 1,736 | 1,935 | 1,700 | 1,864 | +159 | +9.3% | 5,741,100 |
| 2025/06/04 | 1,655 | 1,830 | 1,643 | 1,705 | +52 | +3.1% | 3,330,600 |
| 2025/06/03 | 1,527 | 1,740 | 1,525 | 1,653 | +120 | +7.8% | 3,566,800 |
| 2025/06/02 | 1,520 | 1,550 | 1,460 | 1,533 | +37 | +2.5% | 873,300 |
| 2025/05/30 | 1,690 | 1,698 | 1,456 | 1,496 | -171 | -10.3% | 2,398,200 |
| 2025/05/29 | 1,610 | 1,711 | 1,593 | 1,667 | +32 | +2% | 1,953,500 |
| 2025/05/28 | 1,620 | 1,658 | 1,585 | 1,635 | +13 | +0.8% | 1,184,600 |
| 2025/05/27 | 1,701 | 1,787 | 1,620 | 1,622 | +7 | +0.4% | 4,591,900 |
| 2025/05/26 | 1,590 | 1,660 | 1,551 | 1,615 | +4 | +0.2% | 2,015,400 |
| 2025/05/23 | 1,723 | 1,767 | 1,605 | 1,611 | -134 | -7.7% | 2,868,000 |
| 2025/05/22 | 1,827 | 1,893 | 1,735 | 1,745 | -108 | -5.8% | 4,157,500 |
| 2025/05/21 | 1,620 | 1,946 | 1,526 | 1,853 | +271 | +17.1% | 12,684,700 |
| 2025/05/20 | 1,359 | 1,593 | 1,344 | 1,582 | +253 | +19% | 5,341,700 |
| 2025/05/19 | 1,565 | 1,597 | 1,327 | 1,329 | -76 | -5.4% | 2,536,700 |
| 2025/05/16 | 1,263 | 1,505 | 1,261 | 1,405 | +135 | +10.6% | 3,924,000 |
| 2025/05/15 | 1,120 | 1,327 | 1,116 | 1,270 | +90 | +7.6% | 3,135,200 |
| 2025/05/14 | 1,186 | 1,265 | 1,159 | 1,180 | +20 | +1.7% | 1,705,800 |
| 2025/05/13 | 1,088 | 1,186 | 1,071 | 1,160 | +123 | +11.9% | 2,164,200 |
| 2025/05/12 | 1,076 | 1,080 | 1,012 | 1,037 | -51 | -4.7% | 1,267,500 |
| 2025/05/09 | 1,239 | 1,250 | 1,059 | 1,088 | -61 | -5.3% | 4,910,200 |
| 2025/05/08 | 1,044 | 1,149 | 1,036 | 1,149 | +150 | +15% | 885,100 |
| 2025/05/07 | 999 | 1,012 | 992 | 999 | -18 | -1.8% | 256,100 |
| 2025/05/02 | 998 | 1,026 | 992 | 1,017 | +21 | +2.1% | 273,400 |
| 2025/05/01 | 1,028 | 1,040 | 995 | 996 | -32 | -3.1% | 341,900 |
| 2025/04/30 | 1,020 | 1,028 | 1,002 | 1,028 | +13 | +1.3% | 205,900 |
| 2025/04/28 | 1,023 | 1,066 | 1,015 | 1,015 | +6 | +0.6% | 272,900 |
| 2025/04/25 | 1,010 | 1,036 | 1,008 | 1,009 | -4 | -0.4% | 221,200 |
| 2025/04/24 | 1,000 | 1,027 | 995 | 1,013 | +14 | +1.4% | 254,200 |
| 2025/04/23 | 1,027 | 1,040 | 992 | 999 | -17 | -1.7% | 341,100 |
| 2025/04/22 | 1,020 | 1,031 | 997 | 1,016 | -17 | -1.6% | 330,600 |
| 2025/04/21 | 1,038 | 1,046 | 1,017 | 1,033 | -12 | -1.1% | 209,800 |
| 2025/04/18 | 1,030 | 1,080 | 1,030 | 1,045 | +9 | +0.9% | 319,700 |
| 2025/04/17 | 1,020 | 1,036 | 1,012 | 1,036 | +7 | +0.7% | 139,900 |
1～
50
件表示中 / 922件
類似銘柄と比較する
現在ご覧いただいている「レナサイエンス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| レナサイエンス | 181,300円 | -14.4% | - | 0.00% | - | 13.40倍 |
|
東北大発創薬ベンチャー。創業者の宮田同大教授が発見した低分子化合物を使い治療薬を開発 |
| ミズホメディ | 144,500円 | -20.7% | -41.2% | 5.88% | 12.32倍 | 1.59倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| ＣＡＮＢＡＳ | 119,500円 | - | - | 0.00% | - | 7.89倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| アンジェス | 6,300円 | +110.0% | - | 0.00% | - | 10.84倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
| 扶桑薬 | 212,000円 | +1.6% | -12.7% | 4.25% | 7.87倍 | 0.55倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
市場注目の銘柄
チャート関連のコラム
